Goal and Learning Outcomes

The goal of this course is to help healthcare professionals understand, recognize, and describe medical family therapy.
 
The author does not have any conflict of interest and would like to thank the American Association for Marriage and Family Therapy for the permission to use the content of the MedFT core competencies in this project. More specifically the eight scholars who helped bring the MedFT competency project/table to the finish line: Jennifer Hodgson Ph.D., Angela Lamson Ph.D., Tai Mendenhall Ph.D., Randall Reitz Ph.D., Laura Sudano Ph.D., Stephanie Trudeau M.S., Lisa Tyndall Ph.D., and Jackie Williams-Reade Ph.D.
 
After taking this course, you should be able to:
  • Define the field of medical family therapy and its applications.
  • Recognize the six areas of competency in medical family therapy and their applications.
  • Identify the role of the integrated healthcare system.

Accreditation Information

NURSES

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

 

CEBroker

Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and  West Virginia Board Of Examiners For Registered Professional Nurses

 

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

 

Disclosures

None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.